Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cemindo Gemilang Tbk. (CMNT) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Cemindo Gemilang Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Cemindo Gemilang Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Cemindo Gemilang Tbk. trades at Rp795 (market cap 13.36T, 25.12M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume). The key difference: Cemindo Gemilang Tbk. is far larger — about 21× UBC Medical Indonesia Tbk.'s market cap, and Cemindo Gemilang Tbk. is more actively traded (25.12M versus 843K). Which is the better fit depends on your goals.

CMNTLABS
Market Cap
13.36T635.95B
Volume
25.12M843K
Lot
251.24K8.43K
Turnover
20.08B137.6M
Average Price
799.24163.22
Value
20.08B137.6M
Indicative Equilibrium Price
795165
Indicative Equilibrium Volume
512246

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CMNT
View details
LABS
View details

About Cemindo Gemilang Tbk.

PT Cemindo Gemilang Tbk (the “Company”) was established in Indonesia based on Notarial Deed No. 9 of Humberg Lie, S.H., S.E., M.Kn, dated July 4, 2011.

Read more on CMNT

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS